Racing CRISPR into Diagnostics

CRISPR is revolutionising all areas of life sciences. Its flexibility means that CRISPR-based detection can be applied to industries like agriculture, environmental monitoring, biodefense and more.

Now race is on to get it into diagnostics.

This would bring countless benefits including quicker and more accurate results for both infectious and non-infectious disease.

It would also move many areas of diagnostics closer to the point of care (PoC), with heavy-duty machinery, like PCR instrumentation, no longer required. The stability of the CRISPR-Cas protein complexes means they’re easily handled and transported too, which would make CRISPR diagnostics highly accessible.

Two start-ups are now battling to get this to market first: Mammoth Biosciences and Sherlock Biosciences.

Please read my full article on how CRISPR can be introduced to diagnostics, why this will be revolutionary and what technologies are coming to market soon.